Peers of Alto Neuroscience Inc (ANRO)
Health Care · Pharmaceuticals
Market cap divided by free cash flow over the last 12 months. Shows how many dollars investors pay for each $1 of yearly cash.
Latest P/FCF Ratio
-11.32x
As of Nov 2, 2026
Beyond P/FCF Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/FCF Ratio |
|---|---|
| Nov 2, 2026 | -11.32x |
| Oct 30, 2026 | -11.52x |
| Oct 29, 2026 | -11.96x |
| Oct 28, 2026 | -11.89x |
| Oct 27, 2026 | -11.82x |
| Oct 26, 2026 | -11.27x |
| Oct 23, 2026 | -11.20x |
| Oct 22, 2026 | -11.32x |
P/FCF Ratio = Market Capitalization / Free Cash Flow (TTM)
P/FCF focuses on actual cash generation rather than accounting profit.
Read the general P/FCF Ratio definition, formula, and analyst usage guide.
P/FCF Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
